| Date | Name | Title | Type | Shares Traded | Price Range | |||
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2009 | vagelos p roy | Director | Disposition (Non Open Market) | 11,837 | n/a | |||
| Jun 23, 2009 | vagelos p roy | Director | Acquisition (Non Open Market) | 50,384 | n/a | |||
| Jun 23, 2009 | vagelos p roy | Director | Disposition (Non Open Market) | 50,384 | n/a | |||
| Apr 27, 2009 | roberts william | Officer | Automatic Sell | 15,160 | 12.74 | |||
| Apr 27, 2009 | roberts william | Officer | Option Execute | 15,160 | 6.50 | |||
| Apr 3, 2009 | vagelos p roy | Director | Disposition (Non Open Market) | 14,976 | n/a | |||
| Feb 23, 2009 | brown michael s | Director | Option Execute | 5,000 | 7.66 | |||
| Feb 20, 2009 | baker charles a | Director | Automatic Sell | 10,000 | 18.16 | |||
| Feb 20, 2009 | baker charles a | Director | Option Execute | 10,000 | 7.66 | |||
| Jan 21, 2009 | gilman alfred g | Director | Option Execute | 10,000 | 7.66 | |||
| Jan 6, 2009 | vagelos p roy | Director | Disposition (Non Open Market) | 11,771 | n/a | |||
| Jan 2, 2009 | gilman alfred g | Director | Acquisition (Non Open Market) | 2,000 | n/a | |||
| Jan 2, 2009 | gilman alfred g | Director | Disposition (Non Open Market) | 2,000 | n/a | |||
| Jan 2, 2009 | goldberg murray a | Officer | Option Execute | 1,300 | 7.41 | |||
| Dec 23, 2008 | gilman alfred g | Director | Acquisition (Non Open Market) | 6,000 | n/a | |||
| Dec 23, 2008 | gilman alfred g | Director | Disposition (Non Open Market) | 6,000 | n/a | |||
| Dec 19, 2008 | gilman alfred g | Director | Disposition (Non Open Market) | 1,000 | n/a | |||
| Dec 19, 2008 | vagelos p roy | Director | Option Execute | 130,000 | 7.41 | |||
| Dec 16, 2008 | yancopoulos george | Officer | Automatic Sell | 74,859 | 16.40 - 16.42 | |||
| Dec 16, 2008 | yancopoulos george | Officer | Option Execute | 100,000 | 7.41 | |||
| ||||||||
Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Stock Information
| NASDAQ:REGN
$24.58 + 0.46 |
Sep 3, 2010
4:00 PM ET |
Quotes delay at least 20min., by eSignal.
